Table 4.

Univariate analysis of complications after Hartmann reversal procedure (HRP).

Variable	No complications N = 40	Complications N = 30	Total N = 70	P value
Sex
Male	25	20	45	0.72
Female	15	10	25
Age.
[28–50]	8	4	12	0.464
[51–70]	25	15	40	0.295
[71–90]	7	11	18	0.07
BMI (Kg/m2)	26 (20–33)	26 (20–47)	26 (20–47)	0.43
BMI 18.5–25	32	17	13	0.158
BMI 25–30	23	6	24	0.032
BMI >30	13	7	33	0.432
ASA score ≥3	11	11	22	0.41
Current smoker	18	14	32	0.89
Alcohol (>30 g/day)	20	4	5	0.1
Diabetes	8	3	11	0.21
CKD (GFR <60 ml/mn)	1	3	4	0.181
Hypertension	21	19	40	0.365
CAD	2	2	4	0.58
PAD	2	4	6	0.21
COPD	3	5	8	0.2
Digestive cancer	15	10	25	0.72
Steroids	5	3	8	0.53
Immunosuppressive drugs	3	2	5	0.64
Warfarin	3	2	5	0.64
Time to get reversal (months)	7.9 (3–20)	8.3 (3–18)	8.1 (3–20)	0.53
First surgeon senior	30	20	50	0.445
Median operative time (mn)	196 (65–600)	218 (60–650)	206 (60–650)	0.77
Manual anastomosis	15	9	24	0.65
Diverting stoma	4	2	6	0.48
Albumin (g/l)	36 (26–44)	29 (20–42)	33 (20–44)	0.005
Albumin ≤ 35 g/l	7	17	24	0.002
Hemoglobin (g/dl)	13 (10–16)	12.6 (9–15)	13 9–16)	0.124
Length of stay (days)	15 (7–32)	26 (9–63)	21 (7–63)	<0.0001

BMI. Body Mass Index; CAD. coronary artery disease; COPD. Chronic obstructive pulmonary disease; CKD. chronic kidney disease; DOA. direct oral anticoagulant; GFR. glomerular filtration rate; PAD. peripheral arterial disease.